amyloid-beta peptides (Columbia Technology Ventures/Columbia University)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameamyloid-beta peptides (Columbia Technology Ventures/Columbia University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAmnesiaNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesColumbia Technology VenturesColumbia University
Active IndicationsN/A
Inactive IndicationsAmnesiaNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A